Published online Jan 28, 2025. doi: 10.4329/wjr.v17.i1.100794
Revised: December 2, 2024
Accepted: January 9, 2025
Published online: January 28, 2025
Processing time: 147 Days and 21.2 Hours
Cardiovascular diseases and cancer are leading causes of morbidity and mortality. Patients with malignancies are at increased risk for cardiovascular complications including acute coronary syndromes, chemotherapy or radiation therapy related complications and cardiac metastasis.
We present a case of a 47-year-old female with metastatic cancer on immunotherapy presented with anterior ST elevation myocardial infarction followed by emergent percutaneous coronary intervention in the left anterior descending artery. Echocardiography after 72 hours showed thickening of inferior wall and cardiac magnetic resonance depicted inflammation and necrosis attributable to either cardiac metastasis or immunotherapy induced myocarditis. Biopsy was not performed because of treatment with antiplatelet drugs and a definite diagnosis was achieved after probationary administration of high-dose intravenous methylprednisolone that led to recovery.
In patients with malignancy, chemotherapy-induced cardiovascular complications and cardiac metastasis are common concerns and may coexist with common acute cardiovascular diseases including acute coronary syndromes. In such cases clinical suspicion aided by multimodality imaging is crucial for the diagnosis. A multidisciplinary team approach is required for prompt initiation of the appro
Core Tip: This case report presents a cardio oncology patient who presented with an acute coronary syndrome. However, the clinical presentation as well as the echocardiography findings were suspicious for an alternative diagnosis including immune checkpoint inhibitor-induced myocarditis or cardiac metastasis. Cardiac magnetic resonance aided the final diagnosis and the initiation of the appropriate treatment by the multidisciplinary team. The case highlights the significance of multimodality imaging for the management of cardio-oncology patients.
